Regulation of mammary branching morphogenesis by Slit/Robo1 signaling

Slit/Robo1 信号传导对乳腺分支形态发生的调节

基本信息

  • 批准号:
    8325062
  • 负责人:
  • 金额:
    $ 37.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-29 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A core objective of tissue biology is to understand how cells interact to generate tissues and organs. While great strides have been made in defining signaling pathways that mediate cellular interactions, there is a fundamental gap in our knowledge concerning how these signaling systems are integrated during mammalian organogenesis. Bridging this knowledge gap is important in identifying druggable targets for cancer, as tumor growth and progression is marked by disorganization of tissue structure, and deregulation of specialized cell populations, such as stem cells. The goal of this application is to understand how extracellular factors, SLITs, influence tissue morphogenesis by regulating the proliferation of a single layer of basal cells in which stem cells reside. Here, mammary branching morphogenesis is used as a model system and, guided by strong preliminary data, the following model is investigated in which a key inhibitor of mammary branching, TGF-21, restrains basal cell proliferation and adhesion by upregulating signaling through the SLIT/ROBO1 pathway. This, in turn, controls basal cell growth and branching morphogenesis by increasing the adhesive functions of 2-catenin at the membrane, at the expense of its proliferative functions in the nucleus. A variety of cell biological, imaging and biochemical techniques will be employed, as well as powerful transplant techniques to manipulate genetically modified mammary tissue. Three hypotheses are tested in three Aims: I) that TGF-21 upregulates Robo1 expression, specifically in basal cells, and that this inhibits branching by restraining basal cell growth; II) that SLIT/ROBO1 signaling opposes the actions of canonical WNTs by altering the subcellular localization of 2-catenin and promoting its cell adhesive functions at the expense of its transcriptional functions; and III), that SLITs are non-renewal factors for stem cells that function to counter the self-renewal signals of canonical WNT signaling by regulating 2-catenin. Together, these experiments will have a positive impact on cancer biology of breast and other glandular organs containing basal stem cell subpopulations (e.g. prostate, salivary etc), because they delineate a novel tumor suppressive signaling network that appears to function in stem cells.
描述(由申请人提供):组织生物学的核心目标是了解细胞如何相互作用以产生组织和器官。虽然在定义介导细胞相互作用的信号通路方面已经取得了很大的进展,但在哺乳动物器官发生过程中,这些信号系统是如何整合的,我们的知识还存在根本性的差距。弥合这一知识差距对于确定癌症的可药物靶点非常重要,因为肿瘤的生长和进展是以组织结构的紊乱和特化细胞群(如干细胞)的失调为特征的。本应用程序的目的是了解细胞外因子(SLITs)如何通过调节干细胞所在的单层基底细胞的增殖来影响组织形态发生。本研究以乳腺分支形态发生为模型系统,在强有力的初步数据指导下,研究了以下模型,其中乳腺分支的关键抑制剂TGF-21通过上调SLIT/ROBO1通路的信号来抑制基底细胞的增殖和粘附。这反过来又通过增加2-连环蛋白在膜上的粘附功能来控制基底细胞的生长和分支形态发生,而牺牲了其在细胞核中的增殖功能。将采用多种细胞生物学、成像和生化技术,以及强大的移植技术来操纵转基因乳腺组织。在三个目的下测试了三个假设:1)TGF-21上调Robo1的表达,特别是在基底细胞中,并且通过抑制基底细胞生长来抑制分支;II) SLIT/ROBO1信号通过改变2-catenin的亚细胞定位并以牺牲其转录功能为代价促进其细胞粘附功能,从而反对典型wnt的作用;III),裂隙是干细胞的非更新因子,其功能是通过调节2-catenin来对抗典型WNT信号的自我更新信号。总之,这些实验将对乳腺癌和其他含有基底干细胞亚群(如前列腺、唾液等)的腺体器官的癌症生物学产生积极影响,因为它们描绘了一个新的肿瘤抑制信号网络,似乎在干细胞中起作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LINDSAY E HINCK其他文献

LINDSAY E HINCK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LINDSAY E HINCK', 18)}}的其他基金

Notch/Robo Regulated Mechanisms Governing Cell Fate Acquisition
Notch/Robo 调控细胞命运获取的机制
  • 批准号:
    10578807
  • 财政年份:
    2020
  • 资助金额:
    $ 37.32万
  • 项目类别:
Notch/Robo Regulated Mechanisms Governing Cell Fate Acquisition
Notch/Robo 调控细胞命运获取的机制
  • 批准号:
    10328258
  • 财政年份:
    2020
  • 资助金额:
    $ 37.32万
  • 项目类别:
Regulation of mammary branching morphogenesis by Slit/Robo1 signaling
Slit/Robo1 信号传导对乳腺分支形态发生的调节
  • 批准号:
    8707486
  • 财政年份:
    2011
  • 资助金额:
    $ 37.32万
  • 项目类别:
RE: Regulation of mammary branching morphogenesis by Slit/Robo 1 signaling
RE: Slit/Robo 1 信号调节乳腺分支形态发生
  • 批准号:
    8623914
  • 财政年份:
    2011
  • 资助金额:
    $ 37.32万
  • 项目类别:
Regulation of mammary branching morphogenesis by Slit/Robo1 signaling
Slit/Robo1 信号传导对乳腺分支形态发生的调节
  • 批准号:
    8155265
  • 财政年份:
    2011
  • 资助金额:
    $ 37.32万
  • 项目类别:
Regulation of mammary branching morphogenesis by Slit/Robo1 signaling
Slit/Robo1 信号传导对乳腺分支形态发生的调节
  • 批准号:
    8513371
  • 财政年份:
    2011
  • 资助金额:
    $ 37.32万
  • 项目类别:
Molecular Basis of Slits as Tumor Suppressors Controlling CXCR4/SDF1 in Breast
狭缝作为肿瘤抑制因子控制乳腺 CXCR4/SDF1 的分子基础
  • 批准号:
    7802884
  • 财政年份:
    2008
  • 资助金额:
    $ 37.32万
  • 项目类别:
Molecular Basis of Slits as Tumor Suppressors Controlling CXCR4/SDF1 in Breast
狭缝作为肿瘤抑制因子控制乳腺 CXCR4/SDF1 的分子基础
  • 批准号:
    8063686
  • 财政年份:
    2008
  • 资助金额:
    $ 37.32万
  • 项目类别:
Molecular Basis of Slits as Tumor Suppressors Controlling CXCR4/SDF1 in Breast
狭缝作为肿瘤抑制因子控制乳腺 CXCR4/SDF1 的分子基础
  • 批准号:
    7523685
  • 财政年份:
    2008
  • 资助金额:
    $ 37.32万
  • 项目类别:
Molecular Basis of Slits as Tumor Suppressors Controlling CXCR4/SDF1 in Breast
狭缝作为肿瘤抑制因子控制乳腺 CXCR4/SDF1 的分子基础
  • 批准号:
    7624200
  • 财政年份:
    2008
  • 资助金额:
    $ 37.32万
  • 项目类别:

相似海外基金

I-Corps: Translation Potential of Peptidic Ensembles as Novel Bio-adhesives
I-Corps:肽整体作为新型生物粘合剂的转化潜力
  • 批准号:
    2409620
  • 财政年份:
    2024
  • 资助金额:
    $ 37.32万
  • 项目类别:
    Standard Grant
Architectural design of active adhesives
活性粘合剂的结构设计
  • 批准号:
    2403716
  • 财政年份:
    2024
  • 资助金额:
    $ 37.32万
  • 项目类别:
    Standard Grant
Design of non-swellable adhesives for brain surgery using cyclodextrin inclusion polymer
使用环糊精包合物聚合物脑外科不可溶胀粘合剂的设计
  • 批准号:
    23H01718
  • 财政年份:
    2023
  • 资助金额:
    $ 37.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Meta-material adhesives for improved performance and functionalisation of bondlines
超材料粘合剂可提高粘合层的性能和功能化
  • 批准号:
    EP/W019450/1
  • 财政年份:
    2023
  • 资助金额:
    $ 37.32万
  • 项目类别:
    Fellowship
Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
  • 批准号:
    10741660
  • 财政年份:
    2023
  • 资助金额:
    $ 37.32万
  • 项目类别:
DMREF: Accelerating the Design of Adhesives with Nanoscale Control of Thermomechanical Properties
DMREF:通过热机械性能的纳米级控制加速粘合剂的设计
  • 批准号:
    2323317
  • 财政年份:
    2023
  • 资助金额:
    $ 37.32万
  • 项目类别:
    Continuing Grant
Mag-Cure: A novel method for magnetically induced bonding and de-bonding of thermoset adhesives in the Automotive Industry
Mag-Cure:汽车行业中热固性粘合剂磁感应粘合和脱粘的新方法
  • 批准号:
    10062336
  • 财政年份:
    2023
  • 资助金额:
    $ 37.32万
  • 项目类别:
    Collaborative R&D
Biodegradable, Biocompatible Pressure Sensitive Adhesives
可生物降解、生物相容性压敏粘合剂
  • 批准号:
    10677869
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
Poly(glycerol carbonate) pressure sensitive adhesives for the in vivo closure of alveolar pleural fistulae
用于体内闭合肺泡胸膜瘘的聚(甘油碳酸酯)压敏粘合剂
  • 批准号:
    10746743
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
Enhanced bio-production of difficult to make peptide ingredients for specialty adhesives and personal care
增强用于特种粘合剂和个人护理品的难以制造的肽成分的生物生产
  • 批准号:
    10021363
  • 财政年份:
    2022
  • 资助金额:
    $ 37.32万
  • 项目类别:
    Investment Accelerator
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了